Recent Updates
Recently added Catalysts
XENE Positive Sentiment

Xenon Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference

Wednesday, May 31, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xenon Pharmaceuticals Inc. will present at the 2023 Jefferies Healthcare Conference scheduled for June 7-9, 2023, in New York, NY. The company's President and CEO Ian Mortimer and CFO Sherry Aulin will lead the fireside chat, which will also be available for live streaming and replay on their website. This presentation underscores Xenon's commitment to developing therapies for neurological disorders, particularly epilepsy, as part of its ongoing efforts in addressing unmet medical needs.
Price reaction · baseline $38.37 (2023-05-30 close) · hit after-hours · clean, no other XENE news in the window
day 0 close · peak
+0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Xenon Pharmaceuticals will present at a prominent event, enhancing visibility.
  • Opportunity to showcase their innovative therapeutics focused on neurological disorders.
  • Live webcast allows wider audience engagement and reach.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+56%
120-day peak, hindsight
Typical move
14.4%
average across 4 past catalysts
Cash runway
~39 mo
Minimal dilution risk
Lead asset
XPF-001
Phase 1 · Primary Erythromelalgia

Full Press Release Details

VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2023 Jefferies Healthcare Conference taking place June 7-9, 2023 in New York, NY.
Company Fireside Chat Presentation Details:
Date: Wednesday, June 7, 2023
Time: 9:30 am Eastern Time
Webcast: Register here
Presenters: Ian Mortimer, President and CEO Sherry Aulin, CFO
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Investor/Media Contact:
Xenon Pharmaceuticals Inc.

Frequently Asked Questions

When will Xenon Pharmaceuticals present at the Jefferies Conference?

Xenon Pharmaceuticals will present on June 7, 2023.

Who will be presenting for Xenon Pharmaceuticals?

Ian Mortimer and Sherry Aulin will present at the event.

Where can I watch the Xenon Pharmaceuticals presentation?

The presentation will be available on Xenon's website under the 'Investors' section.

What focus does Xenon Pharmaceuticals have?

Xenon Pharmaceuticals focuses on developing treatments for neurological disorders.

What is the main area of need Xenon targets?

Xenon targets high unmet medical needs in epilepsy therapies.

ShareAdd on Google
Tags: XENE Viatris Investor Conferences Healthcare Xenon Pharmaceuticals neurology healthcare conference epilepsy
Last updated: May 31, 2023

Biotech snapshot

Cash runway
$1245M liquidity · $32M/mo burn
~39 mo
Minimal dilution risk
Lead asset
XPF-001Phase 1
Primary Erythromelalgia →

Catalyst track record

+56%
best trade around XENE's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for XENE.

See every catalyst's timing & PoA →